Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Verghese

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Cancers|December 10, 2021
MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast CancerDiana E Baxter, Lisa M Allinson, Waleed S Al Amri, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2013
Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS)S Soumian, E T Verghese, M Booth, et al.
Molecular Cancer|March 29, 2014
PSMD9 expression predicts radiotherapy response in breast cancerFiona E Langlands, David Dodwell, Andrew M Hanby, et al.
BMC Clinical Pathology|December 17, 2013
An observational study on the expression levels of MDM2 and MDMX proteins, and associated effects on P53 in a series of human liposarcomasNader Touqan, Christine P Diggle, Edlo T Verghese, et al.
Histopathology|October 22, 2011
Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblastsEldo T Verghese, Hrishikesh Shenoy, Victoria J Cookson, et al.
Journal of Cellular and Molecular Medicine|October 6, 2010
Differential regulation of oestrogen receptor β isoforms by 5' untranslated regions in cancerLaura Smith, Rebecca A Brannan, Andrew M Hanby, et al.
Plos One|May 10, 2013
Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancerBaek Kim, Hiba Fatayer, Andrew M Hanby, et al.
Molecular Cancer Therapeutics|December 28, 2019
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast CancerWaleed S Al Amri, Lisa M Allinson, Diana E Baxter, et al.
Plos One|October 6, 2015
Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast CarcinogenesisLaura Smith, Euan W Baxter, Philip A Chambers, et al.
British Journal of Cancer|April 16, 2009
Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activityL J Coleman, M B Peter, T J Teall, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Cancers|December 10, 2021
MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast CancerDiana E Baxter, Lisa M Allinson, Waleed S Al Amri, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2013
Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS)S Soumian, E T Verghese, M Booth, et al.
Molecular Cancer|March 29, 2014
PSMD9 expression predicts radiotherapy response in breast cancerFiona E Langlands, David Dodwell, Andrew M Hanby, et al.
BMC Clinical Pathology|December 17, 2013
An observational study on the expression levels of MDM2 and MDMX proteins, and associated effects on P53 in a series of human liposarcomasNader Touqan, Christine P Diggle, Edlo T Verghese, et al.
Histopathology|October 22, 2011
Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblastsEldo T Verghese, Hrishikesh Shenoy, Victoria J Cookson, et al.
Journal of Cellular and Molecular Medicine|October 6, 2010
Differential regulation of oestrogen receptor β isoforms by 5' untranslated regions in cancerLaura Smith, Rebecca A Brannan, Andrew M Hanby, et al.
Plos One|May 10, 2013
Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancerBaek Kim, Hiba Fatayer, Andrew M Hanby, et al.
Molecular Cancer Therapeutics|December 28, 2019
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast CancerWaleed S Al Amri, Lisa M Allinson, Diana E Baxter, et al.
Plos One|October 6, 2015
Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast CarcinogenesisLaura Smith, Euan W Baxter, Philip A Chambers, et al.
British Journal of Cancer|April 16, 2009
Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activityL J Coleman, M B Peter, T J Teall, et al.
Pageof 8